Immunohistochemical expression of Ki-67 as a marker of proliferation in gallbladder mucosa samples with or without cancer;Proliferación celular en la mucosa de la vesícula biliar no tumoral en colecistitis crónicas litiásicas. Expresión de Ki-67 en matrices de tejidos

Revista Medica de Chile

Volumn 137, Issue 7, 2009, Pages 881-887

  Roa E , Iván ^a   Elorza D , Xabier ^b   Lantadilla H , Soledad ^a   Ibacache S , Gilda ^a   de Aretxabala U , Xabier ^a  

^a UNIVERSIDAD DEL DESARROLLO   (Chile)

^b Hospital San Camilo   (Chile)

Author keywords

Gallbladder neoplasms; Ki 67 antigen; Microarray analysis

Indexed keywords

KI 67 ANTIGEN; TUMOR MARKER;

ARTICLE; CASE CONTROL STUDY; CELL PROLIFERATION; FEMALE; GALLBLADDER TUMOR; HUMAN; MALE; MIDDLE AGED; MUCOSA; PATHOLOGY;

CASE-CONTROL STUDIES; CELL PROLIFERATION; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; MUCOUS MEMBRANE; TUMOR MARKERS, BIOLOGICAL;

EID: 70350009975     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Serra I. [Has gallbladder cancer mortality decrease in Chile?]. Rev Méd Chile 2001; 129: 1079-84.
2. Andia KM, Gederlini GA, Ferreccio RC. [Gallbladder cancer: trend and risk distribution in Chile]. Rev Méd Chile 2006; 134: 565-74.
3. Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, Wistuba II, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Can-cer J Clin 2001; 51: 349-64.
4. Pandey M. Risk factors for gallbladder cancer: a reappraisal. Eur J Cancer Prev 2003; 12: 15-24.
5. Andia ME, Hsing AW, Andreotti G, Ferreccio C. Geographic variation of gallbladder cancer mortality and risk factors in Chile: a population-based ecolo-gic study. Int J Cancer 2008; 123: 1411-6.
6. Wistuba, II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer 2004; 4: 695-706.
7. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003; 4: 167-76.
8. Kodama K, Nakadaira H, Endoh K, Yamamoto M. Geographic clustering patterns in mortality from biliary tract cancer in Japan. Jpn J Cancer Res 1998; 89: 6-11.
9. Kayahara M, Nagakawa T. Recent trends of gallbladder cancer in Japan: an analysis of 4,770 patients. Cancer 2007; 110: 572-80.
10. Roa I, de Aretxabala X, Araya JC, Roa J. Preneoplastic lesions in gallbladder cancer. J Surg Oncol 2006; 93: 615-23.
11. Yamagiwa H, Tomiyama H. Intestinal metaplasia-dysplasia-carcinoma sequence of the gallbladder. Acta Pathol Jpn 1986; 36: 989-97.
12. Vakkala M, Laurila JJ, Saarnio J, Koivukangas V, Syrjala H, Karttunen T et al. Cellular turnover and expression of hypoxic-inducible factor in acute acalculous and calculous cholecystitis. Crit Care 2007; 11: R116.
13. Lamote J, Willems G. DNA synthesis, cell proliferation index in normal and abnormal gallbladder epithelium. Microsc Res Tech 1997; 38: 609-15.
14. Putz P, Willems G. Cell proliferation in the human gallbladder epithelium: effect of distension. Gut 1979; 20: 246-8.
15. Isozaki H, Okajima K, Hara H, Sako S, Mabuchi H. Proliferating cell nuclear antigen expression in the gallbladder with pancreaticobiliary maljunction. J Surg Oncol 1997; 65: 46-9.
16. Lee CS. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in situ and invasive carcinomas of the extrahepatic biliary tract. Cancer 1996; 78: 1881-7.
17. Roa I, Araya J, Shiraishi T, Yatani R, Villaseca M, Wistuba I et al. Proliferating cell nuclear antigen in gallbladder carcinoma. Histopathology 1993; 23: 179-83.
18. Yanagisawa N, Mikami T, Koike M, Okayasu I. Enhanced cell kinetics, p53 accumulation and high p21WAF1 expression in chronic cholecystitis: comparison with background mucosa of gallbladder carcinomas. Histopathology 2000; 36: 54-61.
19. Sai JK, Suyama M, Nobukawa B, Kubokawa Y, Yokomizo K, Sato N. Precancerous mucosal changes in the gallbladder of patients with occult pancreatobiliary reflux. Gastrointest Endosc 2005; 61: 264-8.
20. Colozza M, Azambuja E, Cardoso F, Sotiriou C, Larsimont D, Piccart MJ. Proliferative markers as prognos-tic and predictive tools in early breast cancer: where are we now? Ann Oncol 2005; 16: 1723-39.
21. Stuart-Harris R, Caldas C, Pinder SE, Pharoah P. Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast 2008; 17: 323-34.
22. Rindi G, D'Adda T, Froio E, Fellegara G, Bordi C. Prognostic factors in gastrointestinal endocrine tumors. Endocr Pathol 2007; 18: 145-9.
23. Roa I, Araya JC, Wistuba I, de Aretxabala X. [Gallbladder cancer: anatomic and anatomo-pathologic considerations]. Rev Méd Chile 1990; 118: 572-9.
24. Roa I, Araya JC, Villaseca M, Roa J, de Aretxabala X, Ibacache G. Gallbladder cancer in a high risk area: morphological patterns. Hepatogastroenterology 1999; 46: 1540-6.
25. Goodson WH, 3RD, Moore DH, 2ND, Ljung BM, Chew K, Florendo C, Mayall B et al. The functional relations-hip between in vivo bromodeoxyuridine labeling index and Ki-67 proliferation index in human breast cancer. Breast Cancer Res Treat 1998; 49: 155-64.
26. Bozlu M, Orhan D, Baltaci S, Yaman O, Elhan AH, Tulunay O et al. The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder. Int Urol Nephrol 2002; 33: 59-66.
27. Heenen M, Thiriar S, Noel JC, Galand P. Ki-67 immunostaining of normal human epidermis: comparison with 3H-thymidine labelling and PCNA immunostaining. Dermatology 1998; 197: 123-6.
28. Lu G, Wai SM, Poon WS, Yew DT. Ki67 and doublecortin positive cells in the human prefrontal cortices of normal aging and vascular dementia. Microsc Res Tech 2005; 68: 255-7.
29. Urruticoechea A, Smith IE, Dowsett M. Proliferation marker Ki-67 in early breast cancer. J Clin Oncol 2005; 23: 7212-20.
30. Sougioultzis S, Foukas PG, Tzivras M, Kourtessas D, Gorgoulis VG, Davaris P et al. Alterations in the proliferating compartment of gastric mucosa during Helicobacter pylori infection: the putative role of epithelial cells expressing p27(kip1). Mod Pathol 2003; 16: 1076-85.
31. Holt PR, Moss SF, Kapetanakis AM, Petrotos A, Wang S. Is Ki-67 a better proliferative marker in the colon than proliferating cell nuclear antigen? Cancer Epidemiol Biomarkers Prev 1997; 6: 131-5.
32. Jaskiewicz K, De Groot KM. p53 gene mutants expression, cellular proliferation and differentiation in oesophageal carcinoma and non-cancerous epithelium. Anticancer Res 1994; 14: 137-40.
33. Noda Y, Fujita N, Kobayashi G, Ito K, Horaguchi J, Takasawa O et al. Histological study of gallbladder and bile duct epithelia in patients with anomalous arrangement of the pancreaticobiliary ductal system: compari-son between those with and without a dilated common bile duct. J Gastroenterol 2007; 42: 211-8.
34. Tanno S, Obara T, Fujii T, Mizukami Y, Yanagawa N, Izawa T et al. Epithelial hyperplasia of the gallbladder in children pancreaticobiliary ductal union. Hepatogastroenterology 1999; 46: 3068-73.
35. Tanno S, Obara T, Fujii T, Mizukami Y, Shudo R, Nishino N et al. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union. Cancer 1998; 83: 267-75.
36. Ai Z, Lu W, Qin X. Arsenic trioxide induces gallbladder carcinoma cell apoptosis via downregulation of Bcl-2. Biochem Biophys Res Commun 2006; 348: 1075-81.
37. Tsuchida A, Itoi T, Aoki T, Koyanagi Y. Carcinogenetic process in gallbladder mucosa with pancreaticobiliary maljunction (Review). Oncol Rep 2003; 10: 1693-9.
38. Mano H, Roa I, Araya JC, Ohta T, Yoshida K, Araki K et al. Comparison of mutagenic activity of bile between Chilean and Japanese female patients having cholelithiasis. Mutat Res 1996; 371: 73-7.
39. Takei K, Watanabe H, Itoi T, Saito T. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gallbladder. Pathol Int 1996; 46: 426-35.
40. Hidalgo Grau LA. Gallbladder carcinoma: the role of p53 protein overexpression and Ki67 antigen expression as prognostic factor. HPJ 2004; 6: 174-80.
41. Li SH, Li CF, Sung MT, Eng HL, Hsiung CY, Huang WW et al. Skp2 is an independent prognosticator of gallbladder carcinoma among p27(Kip1)-interacting cell cycle regulators: an immunohistochemical study of 62 cases by tissue microarray. Mod Pathol 2007; 20: 497-507.
42. Jin YM, Yim H, Shim C. Cyclin E expression in benign and malignant epithelial neoplasms of the gallbladder. Yonsei Med J 1997; 38: 301-6.
43. Nagata S, Ajioka Y, Nishikura K, Watanabe G, Inoue T, Yamaguchi K et al. Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: immunohistochemical analysis of mucin profile and CD 10. Oncol Rep 2007; 17: 721-9.